Catalent Inc (CTLT)
59.66
+0.66
(+1.12%)
USD |
NYSE |
Nov 21, 16:00
59.66
0.00 (0.00%)
Pre-Market: 20:00
Catalent Shareholders Equity (Quarterly): 3.542B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.542B |
| June 30, 2024 | 3.604B |
| March 31, 2024 | 3.611B |
| December 31, 2023 | 3.687B |
| September 30, 2023 | 3.841B |
| June 30, 2023 | 4.611B |
| March 31, 2023 | 4.703B |
| December 31, 2022 | 4.912B |
| September 30, 2022 | 4.70B |
| June 30, 2022 | 4.775B |
| March 31, 2022 | 4.632B |
| December 31, 2021 | 4.481B |
| September 30, 2021 | 4.38B |
| June 30, 2021 | 4.274B |
| March 31, 2021 | 4.072B |
| December 31, 2020 | 3.814B |
| September 30, 2020 | 3.679B |
| June 30, 2020 | 3.506B |
| March 31, 2020 | 2.794B |
| December 31, 2019 | 2.323B |
| September 30, 2019 | 2.256B |
| June 30, 2019 | 2.288B |
| March 31, 2019 | 1.621B |
| Date | Value |
|---|---|
| December 31, 2018 | 1.563B |
| September 30, 2018 | 1.529B |
| June 30, 2018 | 1.087B |
| March 31, 2018 | 1.068B |
| December 31, 2017 | 1.006B |
| September 30, 2017 | 1.039B |
| June 30, 2017 | 723.50M |
| March 31, 2017 | 642.70M |
| December 31, 2016 | 588.00M |
| September 30, 2016 | 614.50M |
| June 30, 2016 | 635.90M |
| March 31, 2016 | 602.90M |
| December 31, 2015 | 607.40M |
| September 30, 2015 | 597.20M |
| June 30, 2015 | 634.00M |
| March 31, 2015 | 468.20M |
| December 31, 2014 | 493.30M |
| September 30, 2014 | 503.80M |
| June 30, 2014 | -371.20M |
| March 31, 2014 | -400.00M |
| December 31, 2013 | -414.10M |
| September 30, 2013 | -386.90M |
| June 30, 2013 | -410.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.323B
Minimum
Dec 2019
4.912B
Maximum
Dec 2022
3.997B
Average
3.957B
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.24B |
| Boston Scientific Corp | 20.71B |
| Pfizer Inc | 92.29B |
| Merck & Co Inc | 44.50B |
| BioCardia Inc | 2.753M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.708B |
| Total Liabilities (Quarterly) | 6.166B |
| Debt to Equity Ratio | 1.393 |
| Current Ratio | 2.512 |
| Net Debt Paydown Yield | -0.15% |